Play-Icon

Hansa Biopharma brings portfolio and project management together in Antura

As Hansa Biopharma’s project portfolio grew, the organization needed a clearer way to plan, prioritize and follow up on projects. With Antura, Hansa Biopharma has better visibility of projects, resources and finances and can reduce its reliance on manual processes in Excel and PowerPoint.

Hansa Biopharma is a company within biomedicine and pharmaceutical research. As the business has grown, the need for a more structured way to manage projects, resources and finances has also increased.

Need for better visibility and more efficient ways of working

Hansa Biopharma needed a solution that could provide better support for both portfolio and project management. Among the most important needs were to:

  • replace existing manual ways of working in Excel and PowerPoint

  • gather project information and connect projects to strategies

  • enable prioritization and simulation of project portfolios

  • improve resource management, capacity planning, time reporting and follow-up

  • support project planning with different project models

  • follow up on costs, budgets and results

  • integrate with the company’s existing financial system

Hansa Biopharma manages many projects and subprojects in a complex and knowledge-intensive organization. It was therefore important to find a project and portfolio management tool that could provide structure without limiting ways of working.

 

A shared platform for projects, resources and finances

With Antura, Hansa Biopharma has a central platform for project visibility, planning and follow-up. This creates better conditions for clear decision-making, more efficient resource allocation and better control of project budgets.

By reducing its reliance on manual processes, the organization can also reduce the risk of errors, duplicated work and scattered project information. Instead, important data and processes are gathered in one shared system that supports both day-to-day project management and long-term portfolio management.

 

Hansa is a commercial-stage biopharmaceutical company and a pioneer in the development and commercialization of innovative, life-changing treatments for patients with rare immunological conditions. Founded in 2007 and headquartered in Lund, Sweden. The company also operates in other European countries and the United States. They were listed on Nasdaq First North Growth Market Stockholm from 2007 to 2015 and on Nasdaq Stockholm since 2015.